BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 11889194)

  • 1. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
    Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
    Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans.
    Mellman MJ; Davis MR; Brisman M; Shamoon H
    Diabetes Care; 1994 Mar; 17(3):183-8. PubMed ID: 8174445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GLP-1 and 2,5-anhydro-D-mannitol on insulin secretion and plasma glucose in mice.
    Ahrén B; Lindskog S; van Dijk G; Scheurink AJ; Steffens AB
    Endocr Res; 1995 Aug; 21(3):583-94. PubMed ID: 7588428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.
    Andreasen JJ; Orskov C; Holst JJ
    Digestion; 1994; 55(4):221-8. PubMed ID: 8063025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of physiological hyperinsulinemia on counterregulatory hormone responses during hypoglycemia in humans.
    Mellman MJ; Davis MR; Shamoon H
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1293-7. PubMed ID: 1430091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered responses to hypoglycemia of healthy elderly people.
    Meneilly GS; Cheung E; Tuokko H
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1341-8. PubMed ID: 8200936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation in brain glucose uptake following recurrent hypoglycemia.
    Boyle PJ; Nagy RJ; O'Connor AM; Kempers SF; Yeo RA; Qualls C
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9352-6. PubMed ID: 7937768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.
    Miholic J; Orskov C; Holst JJ; Kotzerke J; Meyer HJ
    Dig Dis Sci; 1991 Oct; 36(10):1361-70. PubMed ID: 1914756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
    Gutniak MK; Linde B; Holst JJ; Efendić S
    Diabetes Care; 1994 Sep; 17(9):1039-44. PubMed ID: 7988303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.
    Schjoldager BT; Mortensen PE; Christiansen J; Orskov C; Holst JJ
    Dig Dis Sci; 1989 May; 34(5):703-8. PubMed ID: 2714145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM.
    Dupre J; Behme MT; Hramiak IM; McFarlane P; Williamson MP; Zabel P; McDonald TJ
    Diabetes; 1995 Jun; 44(6):626-30. PubMed ID: 7789625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.
    Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W
    Acta Diabetol; 1995 Mar; 32(1):13-6. PubMed ID: 7612912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short- or long-term administration.
    Hargrove DM; Nardone NA; Persson LM; Parker JC; Stevenson RW
    Metabolism; 1995 Sep; 44(9):1231-7. PubMed ID: 7666800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
    Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
    Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
    Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
    Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.
    Ritzel R; Orskov C; Holst JJ; Nauck MA
    Diabetologia; 1995 Jun; 38(6):720-5. PubMed ID: 7672496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
    Montrose-Rafizadeh C; Egan JM; Roth J
    Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
    Jia X; Elliott R; Kwok YN; Pederson RA; McIntosh CH
    Diabetes; 1995 May; 44(5):495-500. PubMed ID: 7729605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gastric acid secretion in humans by glucagon during euglycemia, hyperglycemia, and hypoglycemia.
    Loud FB; Holst JJ; Rehfeld JF; Christiansen J
    Dig Dis Sci; 1988 May; 33(5):530-4. PubMed ID: 3359907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.